Thomas A - Search Results

1

End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease.

Thomas A, Bonanni L, Di Iorio A, Varanese S, Anzellotti F, D'Andreagiovanni A, Stocchi F, Onofrj M. Thomas A, et al. J Neurol. 2006 Dec;253(12):1633-9. doi: 10.1007/s00415-006-0320-z. J Neurol. 2006. PMID: 17219034 Clinical Trial.

2

Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease.

Onofrj M, Thomas A, Luciano AL, Iacono D, Di Rollo A, D'Andreamatteo G, Di Iorio A. Onofrj M, et al. Among authors: thomas a. Clin Neuropharmacol. 2002 Jul-Aug;25(4):207-15. doi: 10.1097/00002826-200207000-00004. Clin Neuropharmacol. 2002. PMID: 12151908 Clinical Trial.

3

HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease.

Onofrj M, Luciano AL, Iacono D, Thomas A, Stocchi F, Papola F, Adorno D, Di Mascio R. Onofrj M, et al. Among authors: thomas a. Mov Disord. 2003 Mar;18(3):337-340. doi: 10.1002/mds.10409. Mov Disord. 2003. PMID: 12621640

4

The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition: a part 3 study of the main mechanism of cholinesterase inhibitors in dementia.

Onofrj M, Thomas A, Iacono D, Luciano AL, Di Iorio A. Onofrj M, et al. Among authors: thomas a. Clin Neuropharmacol. 2003 Sep-Oct;26(5):239-51. doi: 10.1097/00002826-200309000-00008. Clin Neuropharmacol. 2003. PMID: 14520164 Clinical Trial.

5

Severe worsening of parkinsonism in Lewy body dementia due to donepezil.

Onofrj M, Thomas A. Onofrj M, et al. Among authors: thomas a. Neurology. 2003 Nov 25;61(10):1452. doi: 10.1212/01.wnl.0000094201.80888.da. Neurology. 2003. PMID: 14638981 No abstract available.

6

Acute akinesia in Parkinson disease.

Onofrj M, Thomas A. Onofrj M, et al. Among authors: thomas a. Neurology. 2005 Apr 12;64(7):1162-9. doi: 10.1212/01.WNL.0000157058.17871.7B. Neurology. 2005. PMID: 15824341

7

Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal.

Thomas A, Onofrj M. Thomas A, et al. Mov Disord. 2005 Dec;20(12):1671; author reply 1671-2. doi: 10.1002/mds.20689. Mov Disord. 2005. PMID: 16149099 No abstract available.

8

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Bonanni L, Thomas A, Onofrj M. Bonanni L, et al. Among authors: thomas a. Neurology. 2006 May 9;66(9):1455; author reply 1455. doi: 10.1212/01.wnl.0000224698.67660.45. Neurology. 2006. PMID: 16682691 No abstract available.

9

Task-specific lower lip dystonia due to mantra recitation.

Bonanni L, Thomas A, Scorrano V, Onofrj M. Bonanni L, et al. Among authors: thomas a. Mov Disord. 2007 Feb 15;22(3):439-40. doi: 10.1002/mds.21268. Mov Disord. 2007. PMID: 17149705 No abstract available.

10

Dopa-responsive pseudo-orthostatic tremor in parkinsonism.

Thomas A, Bonanni L, Antonini A, Barone P, Onofrj M. Thomas A, et al. Mov Disord. 2007 Aug 15;22(11):1652-6. doi: 10.1002/mds.21621. Mov Disord. 2007. PMID: 17579364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,651 results

Search Page